Podme logo
HemUpptäckKategorierSökStudent
Healthcare investment and the outlook for 2021

Healthcare investment and the outlook for 2021

32:032021-04-21

Om avsnittet

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Investment Analyst Scott Power at Morgans to discuss healthcare investment and the outlook for 2021. Malcolm McColl, CEO & Co-Founder of ImmVirX will also join the panel to discuss his experience at Viralytics and what he is now working on.

Senaste avsnitten

Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-06-2237min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-06-011h 2min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-03-2149min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2022-02-1034min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-12-2231min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-11-0842min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-10-2635min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

BioBullets: The Great Dispersion

2021-09-1713min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

Investing in Biotech

2021-09-1337min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech from Horizon 3 Biotech

BioBullets: The Aduhelm FDA approval controversy

2021-08-1310min
logo

PODME

INFORMATION

  • Om kakor
  • Allmänna villkor
  • Integritetspolicy
  • Press

LADDA NED APPEN

app storegoogle play store

REGION

flag
  • sweden_flag
  • norway_flag
  • finland_flag

© Podme AB 2024